| pubmed-article:8859727 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8859727 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8859727 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
| pubmed-article:8859727 | lifeskim:mentions | umls-concept:C0332441 | lld:lifeskim |
| pubmed-article:8859727 | lifeskim:mentions | umls-concept:C0042900 | lld:lifeskim |
| pubmed-article:8859727 | lifeskim:mentions | umls-concept:C0003320 | lld:lifeskim |
| pubmed-article:8859727 | lifeskim:mentions | umls-concept:C0278348 | lld:lifeskim |
| pubmed-article:8859727 | lifeskim:mentions | umls-concept:C1521840 | lld:lifeskim |
| pubmed-article:8859727 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:8859727 | pubmed:dateCreated | 1997-5-13 | lld:pubmed |
| pubmed-article:8859727 | pubmed:abstractText | Patients with metastatic renal cell cancer and metastatic melanoma treated with high-dose interleukin-2-based immunotherapy were prospectively evaluated for the development of vitiligo. All patients seen in the Surgery Branch, NCI Immunotherapy Clinic, who had been followed for at least 1 year were evaluated. Of 104 patients with metastatic renal cancer none developed vitiligo, though vitiligo was seen in 11 of 74 (15%) patients with metastatic melanoma (p2 = 0.0001). No vitiligo was seen in 27 patients who did not respond to immunotherapy, although vitiligo was seen in 11 of 43 (26%) melanoma patients who had an objective response to IL-2-based immunotherapy (p2 = 0.0002). These findings provide further evidence that the presence of a growing melanoma can sensitize patients to melanocyte-differentiation antigens and that the immune response against these antigens is associated with cancer regression in patients undergoing immunotherapy. | lld:pubmed |
| pubmed-article:8859727 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8859727 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8859727 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8859727 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8859727 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8859727 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8859727 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8859727 | pubmed:issn | 1067-5582 | lld:pubmed |
| pubmed-article:8859727 | pubmed:author | pubmed-author:RosenbergS... | lld:pubmed |
| pubmed-article:8859727 | pubmed:author | pubmed-author:WhiteD EDE | lld:pubmed |
| pubmed-article:8859727 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8859727 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:8859727 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8859727 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8859727 | pubmed:pagination | 81-4 | lld:pubmed |
| pubmed-article:8859727 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:8859727 | pubmed:meshHeading | pubmed-meshheading:8859727-... | lld:pubmed |
| pubmed-article:8859727 | pubmed:meshHeading | pubmed-meshheading:8859727-... | lld:pubmed |
| pubmed-article:8859727 | pubmed:meshHeading | pubmed-meshheading:8859727-... | lld:pubmed |
| pubmed-article:8859727 | pubmed:meshHeading | pubmed-meshheading:8859727-... | lld:pubmed |
| pubmed-article:8859727 | pubmed:meshHeading | pubmed-meshheading:8859727-... | lld:pubmed |
| pubmed-article:8859727 | pubmed:meshHeading | pubmed-meshheading:8859727-... | lld:pubmed |
| pubmed-article:8859727 | pubmed:meshHeading | pubmed-meshheading:8859727-... | lld:pubmed |
| pubmed-article:8859727 | pubmed:meshHeading | pubmed-meshheading:8859727-... | lld:pubmed |
| pubmed-article:8859727 | pubmed:meshHeading | pubmed-meshheading:8859727-... | lld:pubmed |
| pubmed-article:8859727 | pubmed:meshHeading | pubmed-meshheading:8859727-... | lld:pubmed |
| pubmed-article:8859727 | pubmed:meshHeading | pubmed-meshheading:8859727-... | lld:pubmed |
| pubmed-article:8859727 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8859727 | pubmed:articleTitle | Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy. | lld:pubmed |
| pubmed-article:8859727 | pubmed:affiliation | Surgery Branch, Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland, USA. | lld:pubmed |
| pubmed-article:8859727 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8859727 | lld:pubmed |
